International Journal of Pharmacology

2005 | 9,241,751 words

The International Journal of Pharmacology (IJP) is a globally peer-reviewed open access journal covering the full spectrum of drug and medicine interactions with biological systems, including chemical, physiological, and behavioral effects across areas such as cardiovascular, neuro-, immuno-, and cellular pharmacology. It features research on drug ...

Isolation and Hypoglycemic Activity of a Novel Pongamiaflavonylflavonol from...

Author(s):

A. Semalty
Department of Pharmaceutical Sciences, H.N.B. Garhwal University Srinagar (Garhwal), India
M. Semalty
Department of Pharmaceutical Sciences, H.N.B. Garhwal University Srinagar (Garhwal), India
P. Kumar
Department of Pharmaceutical Sciences, H.N.B. Garhwal University Srinagar (Garhwal), India
S.R. Mir
Faculty of Pharmacy, Jamia Hamdard, New Delhi, India
M. Ali
Faculty of Pharmacy, Jamia Hamdard, New Delhi, India
S. Amin
Faculty of Pharmacy, Jamia Hamdard, New Delhi, India


Read the Summary


Year: 2012 | Doi: 10.3923/ijp.2012.265.270

Copyright (license): Creative Commons Attribution 4.0 International (CC BY 4.0) license.


[Full title: Isolation and Hypoglycemic Activity of a Novel Pongamiaflavonylflavonol from Pongamia pinnata Pods]

[[[ p. 1 (unverified proofreading) ]]]

[Find the meaning and references behind the names: Life, Data]

Life International Journal of Pharmacology ISSN 1811-7775 Life science alert ansinet Asian Network for Scientific Information

[[[ p. 2 (unverified proofreading) ]]]

[Summary: This page introduces a study on isolating a novel Pongamiaflavonylflavonol from Pongamia pinnata pods for hypoglycemic activity. It highlights diabetes' global impact, the limitations of current treatments, and the growing interest in phytomedicines. The study investigates the hypoglycemic potential of P. pinnata, a plant used in traditional medicine.]

[Find the meaning and references behind the names: Forest, Ali, New, Plant, Doi, Capital, India, Level, Sheet, Key, Standard, Delhi, Risk, Cure, Kumar, Deals, Million, Philippine, Show, Development, Karanja, Cases, Germany, China, Novel, Oral, Blood, Year, Lot, Beach, Given, Jamia, Amin, Russia, Mir, Still, Author, Parts, Study, Avenue, Tree, Tel, Rising, End, Karim]

International Journal of Pharmacology 8 (4): 265-270, 2012 ISSN 1811-7775 DOI: 10.3923/ijp.2012.265.270 2012 Asian Network for Scientific Information Isolation and Hypoglycemic Activity of a Novel Pongamiaflavonylflavonol from Pongamia pinnata Pods 'A. Semalty, 'M Semalty, 'P. Kumar, S.R. Mir, 'M. Ali and "S. Amin 'Department of Pharmaceutical Sciences, H.N.B. Garhwal University Srinagar (Garhwal), India Taculty of Pharmacy, Jamia Ilamdard, New Delhi, India Abstract: Pongamia pinnata (family Papilionaceae) has been used for bronchitis, whooping cough, rheumatic joints and quench dipsia in diabetes. This study deals with the isolation of a new hypoglycemic phytoconstituent from P. pinnata pods. The hypoglycemic activity of the isolated phytoconstituent was evaluated in comparison of the methanolic extract of the pods.. Methanolic extract of P. pinnata pods was fractionated by column chromatography and the isolated compounds were identified by spectral analysis. A new compound named Pongamiaflavonylflavonol was isolated from chloroform: methanol (97:3) eluant. This new isolated compound was studied for hypoglycemic activity in streptozotocin induced diabetic rats. Methanolic extract of P. pinnata pods and pongamiaflavonylflavonol showed significant hypoglycemic activity in streptozotocin-induced hyperglycemic rats after oral administration. At the end of 6 h the new compound showed 12.15% reduction in blood glucose level in comparison of extract. (11.36%) against the standard (16.93%). It can be concluded that the novel Pongamiaflavonylflavonol isolated from F. pinnata pods may be useful as oral hypoglycemic therapeutic agent. This may serve as a lead compound for development of more potent drugs for clinical use in diabetes. Key words: Pongamia pinnata, hypoglycemic activity, streptozotocin, novel Plavonol, antidiabetic phytoconstituent, isolation. INTRODUCTION Diabetes is a life threatening metabolic disorder. Recently WHO has calculated that worldwide almost 3 million deaths per year are attributable to diabetes. The global diabetic population is expected to increase alarmingly in the coming decades, rising to 380 million people in 2025 (WHO, 2011). Developed countries have higher prevalence rates than developing countries. It is estimated that about. 5.4% of the world population would be suffering by the year 2025. India followed by China and the U.S. shall be the capital of in the year 2025. Presently, India, China, the United States, Russia and Germany are the five countries with the largest numbers of people with diabetes (Facts and Figures, WHO 2011). According to data from National Diabetes Fact Sheet of U.S., 25.8 million children and adults in the United States (8.3% of the population) have diabetes. It was also stated that. diabetes is the leading cause of new cases of blindness and kidney failure among adults aged 20-74 years in the US. Moreover, the risk for stroke is 2 to 4 times higher among people with diabetes. Diabetes is the seventh leading cause of death in the United States (American Diabetic Association, 2011). Diabetes is a disease to which only symptomatic relief can be given. The glucose levels can be controlled either by a variety of oral hypoglycemic agents (like sulphonylurea and biguanides etc.) or by the hormone replacement. Therapy (Insulin). But, the complete cure is still to be (and being) explored. Moreover, the presently prescribed antidiabetic drugs show various side effects and compulsion of being dependent on the drugs (Inzucchi, 2002; Semalty and Semalty, 2008). Nowadays, phytomedicines are gaining popularity and widespread acceptance in the treatment of diabetes also. A lot of investigations are being focused to explore the herbal drug and its chief hypoglycemic constituents (Karim et al., 2011). The study focuses on the hypoglycemic activity of Pongamia pinnata which belong to family Papilionaceae commonly known as Karanja. The plant is distributed throughout India as roadside avenue tree in tidal and beach forest. It is used medicinally in India, China, Australia and Philippine Island (Wealth of India, 2003). In Indian traditional system of medicine-Ayurveda, different parts of P. pinnata have been used for bronchitis, whooping cough, rheumatic joints and quench dipsia in diabetes Corresponding Author: A. Semalty, Department of Pharmaceutical Sciences. H.N.B. Garhwal University Srinagar Garhwal-246174, India Tel: 91-1346-211502 265

[[[ p. 3 (unverified proofreading) ]]]

[Summary: This page details the plant's characteristics, distribution, and traditional uses. It explains the extraction and isolation process of the novel compound, Pongamiaflavonylflavonol, using column chromatography and spectral analysis. It also describes the in vivo hypoglycemic activity assessment in streptozotocin-induced diabetic rats, including toxicity studies and experimental groups.]

[Find the meaning and references behind the names: Fruits, Ahmad, Win, Aller, Khan, Ppm, Deg, Bole, Khare, Western, Pellet, Broad, Seed, Crown, Normal, Rivers, Punitha, Dose, Int, Long, Present, Coast, Tms, Meera, Vivo, Gray, October, Javed, Brown, Six, Hertz, Size, Qureshi, Campus, Smooth, Nmr, High, Days, Point, Bark, Chemical, Woody, Classic, Room, Testa, Esi, Record, Constant, Flowers, Fts, Green, Flower, Light, Hamdard, Oil, Buchi, Bank, House, Albino, Short]

Int. J. Pharmacol., 8 (4): 265-270, 2012 (Meera et al., 2003). Its oil is externally applied to cure herpes and eczema (Qureshi and Khan, 2001). The plant extract has also been reported as phytopesticide against. Okra mosaic virus. The yield of crop was found to be highest with maximum plant, height, flower production and fruits formation (Bhyan et al., 2007). P. pinnata is distributed up to the altitude of 1200 m and is the native of western ghat, chiefly found along the bank of rivers. streams or near sea coast at beach and tidal forest. P. pinnata is a medium-sized glabrous tree with short bole and spreading crown up to 18 m high or sometime even more and 1.5 m in girth. Bark is grayish green or browTI. smooth or covered with tubercles, leaves are imparipinnate, leaflets 5-7, ovate or elliptic. Pods are compressed, woody, indehiscent, yellowish gray when ripe, varying in size and shape, elliptic to obliquely oblong, 4.0-7.5 cm long and 1.7-3.2 cm broad with short curved beak. Seed usually I rarely 2, elliptical or reniform 1.7-2.00 cm long and 1.2-1.8 cm broad, wrinkled with reddish brown leathery testa (Khare, 2004). The plant flowers for a short period, so the pods may be used alternatively. Therefore, the pods were screened for the potential antidiabetic activity. A significant antihyperglycemic and antilipidperoxidative activity of P. pinnata flowers have been already reported in streptozotocin induced diabetic rats but the activity has not been reported in pods (Punitha et al., 2006; Shirwaikar et al. 2003). Therefore, in the present study hypoglycemic activity of P. pinnata pods was investigated in streptozotocin induced diabetic rats against the standard (glibenclamide). A new phytoconstituent was isolated from pods and its hypoglycemic activity was studied in comparison of the methanolic extract of the pods. MATERIALS AND METHODS Plant material: The pods and flowers of P. pinnata were collected from Jamia IIamdard campus in October 2006 and were identified by Dr. Javed Ahmad, Department of Botany, Jamia Ilamdard. (Voucher No. PRL-001-06). The voucher specimens are kept for the record in Department. of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Jamia Hamdard, New Delhi. Flowers pods were dried for 7 days in air and latter at temperature below 45°C in an oven (2.2 kg). Extraction and of isolation novel pongamiaflavonylflavonol: The dried flower pods were coarsely powdered and extracted with water and methanol at room temperature. The extracts were vacuum dried in rotator vacuum film evaporator (Perfit Model No. 5600 Buchi type). The methanolic extract yielded as a viscous residue (160 g). The fractionation of methanolic residue was carried out in column with solvents in increasing polarity viz., pet ether, chloroform and methanol. Elution of the column with chloroform: methanol (97:3) yielded a compound (PP1) of green amorphous powder mature and recrystallized from methanol (140 mg). The melting point was obtained on a Perfit apparatus. Both 'H and 13C-NMR spectra were recorded with a Bruker Advance 003 version, Germany NMR instrument operating al 400 and 100 MHz, respectively. The spectral were recorded in deuterated dimethyl sulfoxide (DMSOd) using trimethylsilane (TMS) as internal standard with chemical shift o expressed in ppm and coupling constant (J) in Hertz. The IR Spectra were obtained in KBr pellet on Win IR FTS-135 instrument (Biored, USA). ESI MS scanned at 70 eV on a Jeol D-300 instrument (Jeol, USA). In vivo hypoglycemic activity Animal: Colony bred, healthy Wistar Albino rats were obtained from the animal house of Jamia Hamdard, New Delhi, after obtaining approval from institutional ethical committee. All the animals were weighted (200-250 g) and marked separately. Animals having similar weight and sex were kept in same group. The ammals were housed in standard cages (48×35×22 cm) at room temperature (25+2°C), with artificial light from 7.00 am to 7.00 pm and provided with pelleted food and water ad libitum. Acute toxicity study: Acute toxicity was performed for aqueous extrael according to the acute toxic classic method as per guidelines of Organization for Economic Cooperation and Development (OECD, 1996). Albino Wistar rats were used and amimals were kept fasting for overnight providing only water, aller which the extract. was administered orally at the dose of 200 mg kg and observed for 21 h. If the mortality was observed in two out of three animals, then the dose administered was assigned as toxic dose. If the mortality was observed in one animal, then the same dose was repealed to confirm the toxic dose. If mortality was not observed, the procedure repeated for further higher dose i.c.. 2000 mg kg One tenth of maximum dose of the extract tested for acute toxicity was selected as dose i.e., 200 mg kg-1 Hypoglycemic activity: Albino Wistar rats (200-250 g) were randomly divided into six groups with six amimals in each group. Except the group I (normal control), in animals of all other groups, diabetes was induced by injecting 266

[[[ p. 4 (unverified proofreading) ]]]

[Summary: This page outlines the experimental procedure for evaluating hypoglycemic activity. It details the induction of diabetes in rats using streptozotocin and the treatment groups, including a control, a standard drug (glibenclamide), a methanolic extract of P. pinnata pods, and the isolated compound PP-1. Blood samples were collected to measure blood sugar levels, and statistical analysis methods are mentioned.]

[Find the meaning and references behind the names: Sugar, Log, Bis, Four, Brs, Shinoda, Fig, Rel, Cilo, Ome, Pod, Dry, Iii, Proton, Mass, Rat, Tube, Maxima, Mean, Due, Ion, Cmc, Peak, Sem]

Int. J. Pharmacol., 8 (4): 265-270, 2012 Streptozotocin (50 mg kg i.p. for 4 consecutive days) which was freshly prepared in citrate buffer (pH 4.5). After 4 days these hyperglycemic rals were used for the study: • ■ • • ■ Group 1: (normal control) rats received only buffer (orally) Group II: (diabetic control) these rals were kept. without any treatment to study the diabetic nature of rat Group III: (standard) received the reference standard drug glibenclamide (3 mg kg) administered orally Groups IV: (P. pinnata pods methanolic extracts): P. pinnata pods methanolic extract (200 mg kg) in 1% CMC through oral route Groups V: (pure compound PP-1) received new isolated difurano flavonoids (50 mg kg ) in 1% CMC through oral route Aller ministration of standard, extract. or new compound the blood samples were taken from the orbital sinus of each rat at 0, 2nd, 1th and 6th h with the help of a capillary tube for the estimation of blood sugar (Semnally and Serally, 2008). Statistical analysis: The data are represented as mean±SEM and statistical significance between treated, untreated and control group was analyzed by ANOVA followed Durmell's multiple comparison tests. Student's t-test. The p<0.05 implies significance. RESULTS AND DISCUSSION Extractive yield of methanolic extract of pods was 7.2% of dry plant. Methanolic extract of P. pinnata was fractionated by column chromatography and isolate named Pongamiallavonylflavonol (PP1), as a green amorphous powder from chloroform: methanol (97:3). eluant. It responded positively to Shinoda test (Danmalam et al., 2009) indicating flavonoid nature of the molecule. The compound was characterized for melting point and various spectral analyses. Its UV spectrum showed absorption maxima at 221, 264 and 322 nm typical to flavones. The IR spectrum of Pongamia lavonylflavonol displayed characteristic absorption bands for hydroxyl (3257, 3160 cm and carbonyl (1667 cm) groups. The Its mass spectrum showed molecular ion peak at m/z 642 corresponding to a billavone moiety, CH prominent ion fragments generated m/z 311 and 331 indicated the attachment of tetrahydroxy-methoxyflavone with a dihydroxy-methoxy ethyl flavonone. The prominent ion peak at m/z 300 was formed due to removal of methoxy group from the mass unit al m/z 331. CH₁ 2"a OH 3'a 2'a OMe 1"a CH₂ 4'a 8a 9a 0 2a 5'a 7a 6'a 10a 6a Za 4a 5a OH OH HO 3'b OMe 2'b 4'b 8b HO 0 2b 5'b 1'b 7b 6'b 3b 6b 5b 4b OH OH structure of novel Fig. 1 Chemical antihyperglycemic compound PP1 isolated 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 0 -1 -2 ppm Fig. 2: 'H NMR spectrum of compound PPI (DMSO-d;) Pongamiaflavonylflavonol (5a, 3'a, dihydroxy-4'amethoxy 8-ethylflavonyl (6a 8b)-5b, 7b, 2'b, 3'btetramethoxy-4b-methoxyflavonol) (Fig. 1). m.p 240-242°C, UV (MeOH): 221, 264, 322 nm (log c 5.6, 3.2, 4.8); IR V (KBr): 3257, 3160, 2921, 2852, 1667, 1579, 1503, 1448, 1367, 1288, 1252, 1170, 1069. 1027,832 cm 11 NMR (DMSO-d): 8 7.94 (111, d, J = 8.8 Hz, H-5'a), 7.81 (1H, brs. H-6b), 7.77 1H, d, J-8.4 Hz, H- 5b), 7.73 (1H, d, J = 8.4 Hz, H-6°b), 7.46 (1H, d, J = 8.8 Hz H-6a), 7.18 (1H, bis, H-3a), 6.88 (1H, d, J - 2.5 Hz, H-2'a). 6.63 (III, brs, II-7a), 3.95 (611, brs, 2×OMe), 2.16 (211, brs, H-1a), 0.84 (3H, J 6.3Hz. Me-2"a), "C NMR (DMSOd) LIMS m/z (rel. int.) 612[M] (CILO) (11.3), 331 (100), 311 (22.1), 300 (80.3) (Fig. 2 al 3). The II NMR spectrum (Fig. 2) of compound isolated from the pod extract showed four one proton doublets at 7.91 (J 8.8 Hz), 7.77 (J= 8.1 Hz 7.73 (J=8.1 Hz) and 267

[[[ p. 5 (unverified proofreading) ]]]

[Summary: This page presents the spectral analysis data (13C NMR) of Compound PP1, assigning peaks to specific protons and carbons, and comparing it with related flavonoid molecules. It also discusses the in vivo hypoglycemic activity results, showing that both the methanolic extract and Compound PP1 significantly reduced blood glucose levels in diabetic rats, comparable to the standard drug.]

[Find the meaning and references behind the names: Natural, Body, Time, Carbon, Part, Doublet, Hand, Ortho, Table, Meta, Good]

Int. J. Pharmacol., 8 (4): 265-270, 2012 Fig. 3: C NMR spectrum of Compound PPI 7.46 (J 8.8 Hz) assigned to ortho- coupled H-S'a, H-5'by H-6*b and H-6 a respectively. A one-proton doublet at 6.88 with coupling interaction of 2.5 IIz was ascribed to meta-coupled H-2 a. Three one proton signals at ò 7.81. 7.18 and 6.63 were allributed to aromatic H-6b. H-3a and H-7a, respectively. A six-proton broad signal at 6 3.95 was accounted to two methoxy protons. A two-proton broad signal at $ 2.46 was associated with the methylene H₂-1"a protons. A three-proton triplet at 8 0.84 (J 6.3 Hz) was assigned to primary methyl H-2'a protons. The "CNMR spectrum (Fig. 3) exhibited signals for carbonyl carbon at 8 177.61 (C-4a) and 177.46 (C-4b), aromatic carbon between 8 163.11- 104.33, methoxy carbons at 8 56.34. methylene carbon al 8 29.55 and methyl carbon at & 14.53. The absence of carbon signals near & 95.0 supported flavones moiety attachment at C-8b, with C-6 of a flavanol part. The 'H NMR and 13C NMR signals of Pongamiaflavony flavonol were compared with the related flavonoids molecules. Ahmad et al. (2004) isolated and reported 3-0-b-d-glucopyranosyl[23:7,8] 6-methoxy-3-0-b-dglucopyranosyl furanoflavone, [278] Gigano Pihote, 3-methoxy-6-0-b-dlglucopyranosyl [2.3:7,8] furanoflavone and 3-methoxy- 3',4'-methylenedioxy-7-0-b-d-glucopyranosyl flavone and named those as pongamoside A, B, C and D, respectively from fruits of P. pinnata. This supports the present stakly in terms of the presence of flavonoids in the fruits. Therefore, the abundance of flavonoids was most likely in pod extract also. On the basis of spectral data analysis chemical Teac❘ 1071. The structure of Pongamiaflavonylflavonol has been established as 5a, 3'a, dihydroxy-1'a- methoxy 8-ethylflavonyl (6a-8b)-5b, 7b, 2.b, 3'b-tetramethoxy-4'b-methoxyflavonol (Fig. 1). This is a new molecule isolated from a natural or synthetic source for the first time. an In vivo hypoglycemic activity: In the present study, a comparative chronic antidiabetic study was carried out between methanolic extract and new compound (PPI) of P. pinnata pods. The dose of 200 mg kg body weight per oral did not produce any toxic effect. Administration of Streptozotocin (50 mg kg) led to elevation of blood glucose level. A comparative antidiabetic sturly was carried out between methanolic extract and new compound (PPI) of P. pinnata pods. Treatment with oral methanolic extracl of P. pinnala pods and Pongamiaflavonylflavonol (PPI) elicited hypoglycemic activity on blood glucose level significantly p<0.01 in normal rats (Table 1). In normal rats, the initial blood glucose level of 81.18-3.32 mg/100 mL was reduced to 68.13±4.11, 63.44±3.55 and 55.12±3.12 mg/100 ml, a the end of 2, 4 and 6 h, respectively with the extract. On the other hand, with the new compound PP1, the initial blood glucose level of 83.55-3.45 mg/100 ml. was reduced to 53.54±1.12, 56.58±3.76 and 61.87±1.16 mg/100 mL at the end of 2, 4 and 6 h, respectively (Table 1). It was observed that in STZ induced diabetic rats after 6 h blood glucose level was reduced by 11.36% (from 288.25 to 255.51 mg/100 mL). 16.93% (from 281.85 to 231.12 mg/100 mL) and 12.15% (from 283.13 to 247.56 mg/100 mL) with P. pinnata pods methanolic extrael. (200 mg kg), standard (Glibenclamide 3 mg kg) and new compound PPI (50 mg kg), respectively (Table 2). Therefore, after 6 h of treatment. antidiabetic activity was found to be in the decreasing order of Std. (Glibenclamide 3 mg kg compound PPI (50 mg kg > P. pinnala pods' extract. (200 mg kg ) in the STZ induced diabetic rats. The compound PP1 showed the hypoglycemic activity comparable to that of stanklard Was a In previous investigations on P. pinnata, the hypoglycemic activities have been reported in flower and bark also (Punitha et al., 2006; Badole and Bodhankar, 2009a, b). All these studies support the presence of hypoglycemic activity in various parts of the plant and also flavonoid compounds responsible for hypoglycemic activities. P. pinnata Nower ex Irael. reported to have good antihyperglycemic hypolipidemic activity which was found comparable to the standard drug glibenclamide (Punitha et al., 2006). Badole isolated new antiheperglycaemic compound - Cycloart-23-ene-3SS, 25diol from stem bark of P. pinnata (Badole and Bodhankar, 2009a). It was also reported that the concomitant administration of petroleum ether extract of the stem bark with glyburide, pioglitazone or metformin showed a synergistic antihyperglycaemic effect. (Badole and Bodhankar, 2009b). This study is well supported by a previous study by authors, in which a new difuranoflavonone compound PP (named Pongamiaflavonol) was isolated from methanolic extract 268

[[[ p. 6 (unverified proofreading) ]]]

[Find the meaning and references behind the names: Pharm, Yadav, Saif, Sattar, Maurya, Sci, York, Nig, Sohail, Linn, Alam, Abdullahi, Munir, Med, Pierre, Musa, Springer, Focus]

Int. J. Pharmacol., 8 (4): 265-270, 2012 Table 1: Effect of methanolic extract of P. pinnata pods and Pongamiaflavonylflavonol (PP1) on blood glucose level in normal rats Blood glucose level mg/100 mL Drug Dose (mg kg¹p.a.) Control Extract Glibenclamide PPI 200 3 50 All values are Mean+SEM, n = 6, *Significant at p<0.01 Initial 83.165.10 2 h 82.83±3.11 4 h 83.01-3.12 6 h 83.11=3.14 84.18+3.32 68.13±4.11* 63.44-3.55* 55.12=-3.12* 84.13±2.15 83.55±3.45 45.83±4.27* 53.54±4.12* 44.54-3.45* 56.58-3.76* $2.21-5.55* 61.87=4.16* Table 2: Titfect of methanolic extract. of P. piwata pods and Pongamiatlavonylflavonol (PPI) on blood glucose level in streptozotocin induced hyperglycemic rats Blood glucose level mg/100 ml. Dnig Control Extract Glibenclamide PPI Dose (mg kg..) 200 3 50 Initial 2 h 282.11+8.45 279.22+7.11 4 h 228.12+11.64 6h 285.77+9.23 288.25+9.88 258.56+7.11 281.85+9.77 283.13+8.12 245.38+9.58* 243.43+8.61* 228-1.12** 224.15+9.55* 234.22+10.13* 255.51-7.45** 234.12+9.96* 247.56-11.07* All values are Mean±SEM, n − 6, *.**Significant at p<0.01 and p<0.05, respectively of P. pinnata pods (Kumar et al, 2010). The compound PP showed the significant hypoglycemic and hypolipidemic activity like that of aqueous pods and Plower extract of Pongamia. The present study supported the presence of antihyperglycemic activity of the plant with a focus on activity of flower pod extract. The activity of the novel compound (PPI) from the flower pod extract of P. pinnata has been explored and reported very first time. CONCLUSIONS Therefore, it can be concluded that methanolic extract of P. pinnata pods and a novel isolated molecule Pongamiaflavonylflavonol (PP1) significantly decreased blood glucose level in normal and STZ-induced diabetic rats. It can be concluded that the Pongamiaflavonylflavonol may be useful as oral hypoglycemic therapeutic agent. This may serve as a lead compound for development of more polent drugs for clinical use in Diabetes. ACKNOWLEDGMENTS novel Authors acknowledge Sophisticated Analytical Instrument Facility (SAIF), CDRI Lucknow for providing analytical services and Jamia Hamdard (Hamdard University) New Delhi for providing other necessary facilities. REFERENCES Ahmad, G., P.P. Yadav and R. Maurya, 2001. Furanoflavonoids glycosides from Pongamia pinnata. Phytochemistry, 65: 921-924. American Diabetic Association, 2011. Diabetes statistics. Data from the 2011 National Diabetes Fact Sheet, http://www.diabetes.org/diabetes-basics/diabetesstatistics/ Badole, S.L. and S.L. Bodhankar 2009a. Antihyperglycaemic activity of cycloart-23-ene-313, 25-diol Isolated from stem bark of Pongamia pinnata in alloxan induced diabetic mice. Res. J. Phytochem., 3: 18-24. Badole, S.L. and S.L. Bodhankar, 2009b. Concomitant administration of petroleum ether extract of the stem bark of Pongamia pinnata (L.) pierre with synthetic oral hypoglycaemic drugs in alloxam-induced diabetic mice. Eur. J. Integrative Med., 1: 73-79. Bhyan, S.B., M.M. Alam and M.S. Ali, 2007. Effect of plant extracts on Okra mosaic virus incidence and yield related parameters of Okra Asian J. Agric. Res.. 1: 112-118. Danmalam, U.II., L.M. Abdullahi, A. Agunu and K. Y. Musa, 2009. Acute toxicity studies and hypoglycemic activity of the methanol extract of the leaves of hyptis Suaveolens poit. (Lamiaceae). Nig. J. Pharm. Sci., 8: 87-92. Inzucchi, S.E., 2002. Oral antihyperglycemic therapy for type 2 diabetes: Scientific review. J. Am. Med. Assoc, 287: 360-372. Karim, A., M.N. Sohail, S. Munir and S. Sattar, 2011. Pharmacology and phytochemistry of Pakistani herbs and herbal drugs used for treatement of diabetes. Int. J. Pharmacol., 7: 419-439. Khare, C.P., 2001. Encyclopedia of Indian Medicinal Plants. Springer, New York, USA. Kumar, P., A. Semalty, S.R. Mir, M. Ali and S. Amin, 2010. Hypoglycemic and hypolipidemic activity of Pongamia pinnata (Linn.) pierre in streptozotocininduced diabetic rats. Int. J. Pharmacol., 6: 738-743. 269

[[[ p. 7 (unverified proofreading) ]]]

[Summary: This page lists the references cited in the study, including research articles and publications from organizations like WHO and OECD. These references provide context and support for the study's background, methodology, and findings related to diabetes, plant-based medicine, and experimental procedures.]

[Find the meaning and references behind the names: Malini, Raw, Vasudevan, Tricia, Manoharan, Kumari, Pharmacist, Arom]

Int. J. Pharmacol., 8 (4): 265-270, 2012 Meera, B., S. Kumar and S.B. Kalidhar, 2003. A review of the chemistry and biological activity of Pongamia pinnata. J. Med. Arom. Plant Sci., 25: 111-165. OECD., 1996. Guidelines for testing of chemicals. Test No. 425 http://www.oecd.org/data0ecd/S /11/33663321.pdf Puha, R., K. Vasudevan and S. Manoharan, 2006. FITect. of Pongamia pinnata flowers on blood glucose and oxidative stress in alloxan induced diabetic rats. Indian J. Pharmacol., 38: 62-63. Qureshi, S.J. and M.A. Khan, 2001. Ethnobotanical study of Kahuta from Rawalpindi District Pakistan. J. Biol. Sci., 1: 27-30. Semalty, M. and A. Semalty, 2008. Hypoglycaemic activity of Ficus bengalensis in alloxan induced diabetes in albino rats. Indian Pharmacist, 7: 61-61. Shirwaikar, A., S. Malini and S.C. Kumari, 2003. Protective effect of Pongamia pinnata flowers against cisplatin and gentamicin induced nephrotoxicity in rats. Indian J. Exp. Biol., 41: 58-62. WIIO, 2011. Facts and figures about diabetes. World Health Organization, Switzerland. http://www.who.int/diabetes/facts/en/ Wealth of India, 2003. A Dictionary of Raw Materials. CSIR, New Delhi, Tricia, pp: 206-211 270

Other Health Sciences Concepts:

[back to top]

Discover the significance of concepts within the article: ‘Isolation and Hypoglycemic Activity of a Novel Pongamiaflavonylflavonol from...’. Further sources in the context of Health Sciences might help you critically compare this page with similair documents:

Ayurveda, Karanja, Pongamia pinnata, Blindness, Flavonoid, Insulin, Diabetes, Statistical analysis, Who, Wealth of India, Developing countries, Developed countries, Acute toxicity, Hormone Replacement Therapy, Hypolipidemic activity, Traditional System of Medicine, Antidiabetic activity, Antidiabetic Drug, Metabolic disorder, Hypoglycemic activity, Diabetic control, Acute toxicity study, Synergistic effect, Indian traditional medicine, Antihyperglycemic activity, ANOVA, Student's t test, Normal control, Hypoglycemic activities, American Diabetic Association, Methanolic extract, Antidiabetic study, Glibenclamide, Animal house, Phytomedicine, Column chromatography, Blood glucose level, Streptozotocin, Chemical structure, Toxic effect, Clinical use, Herbal drug, Oral Hypoglycemic Agent, Cardiovascular risk, NMR spectrum, IR Spectra, Mass spectrum, Albino Wistar rats, Kidney Failure, IR spectrum, NMR spectra, STZ induced diabetic rats, Hypoglycemic agent, Shinoda test, Side effect, Department of Botany, UV spectrum, Lead compound, Extractive yield, Spectral analyses, Faculty of pharmacy, Methoxy group, Normal Rats, Phytoconstituent, Wistar albino rat, Leading cause of death, Global diabetic population, Leading cause, Diabetic rat, Antihyperglycaemic effect, Antilipidperoxidative activity, Methoxy protons, Flavone, OECD, Streptozotocin-induced diabetic rat, Diabete, Hamdard University, In vivo hypoglycemic activity, Western ghat, Beach forest.

Let's grow together!

I humbly request your help to keep doing what I do best: provide the world with unbiased sources, definitions and images. Your donation direclty influences the quality and quantity of knowledge, wisdom and spiritual insight the world is exposed to.

Let's make the world a better place together!

Like what you read? Help to become even better: